Mechanisms of Leydig Cell Aging and Obesity-Related Hypogonadism in Men: A Review
Medical Science Monitor · 03.08.2025 · 31
DOI: 10.12659/msm.948180 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Medical Science Monitor, online erschienen am 03.08.2025. Verfasst von Xinshuang Huang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Endocrine Glucose and Lipids Metabolism and Brain Aging, Ministry of Education; Department of Endocrinology, Shandong Provincial Ho…. Hauptthemen laut MEDLINE: Leydig Cells, Hypogonadism, Obesity, Cellular Senescence. Die Arbeit wurde bisher 13-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
The rising prevalence of overweight, obesity, and late-onset hypogonadism (LOH) is seriously affecting the quality of life of middle-aged and older men. LOH is a testosterone deficiency syndrome that is closely associated with aging. Its main symptoms are erectile dysfunction, loss of libido, fatigue, and loss of bone density. Testicular Leydig cells are located in the connective tissue between the spermatogenic tubules and are the primary sites producing testosterone. Metabolic disorders such as obesity and hyperlipidemia accelerate Leydig cell aging, reduce testosterone levels, and contribute to the development of LOH. The pathogenesis of LOH mainly includes oxidative stress, inflammation, mitochondrial dysfunction, and endoplasmic reticulum stress. The treatments for LOH include testosterone replacement therapy, senolytic therapy, stem cell therapy, and traditional Chinese medicine therapy. Obesity may be one of the important mechanisms of obesity-related LOH by promoting Leydig cell aging, changing the endocrine environment, and worsening chronic inflammation, and research in this field is still deepening. Therefore, this article reviews the mechanisms of testicular interstitial cell senescence and obesity-related delayed hypogonadism, as well as possible obesity management methods.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Endocrine Glucose and Lipids Metabolism and Brain Aging, Ministry of Education; Department of Endocrinology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandon…
- Department of Endocrinology, Shandong Provincial Hospital, Shandong University of Traditional Chinese Medicine, Jinan, Shandong, China.
- Department of Endocrinology and Nephrology, PKUCare CNOOC Hospital, Tianjin, China.
- Shandong Key Laboratory of Endocrinology and Lipid Metabolism, Shandong Institute of Endocrinology and Metabolic Diseases, Shandong Engineering Laboratory of Prevention and Control for Endocrine and Metabolic Diseases,…
- "Chuangxin China" Innovation Base of Stem Cell and Gene Therapy for Endocrine Metabolic Diseases, Shandong Engineering Research Center of Stem Cell and Gene Therapy for Endocrine and Metabolic Diseases, Jinan, Shandong,…
Zitieren
APA
Huang, X., Zhao, H., Wu, X., Liang, Y., Guan, Q., Luo, D., & Yu, C. (2025). Mechanisms of Leydig Cell Aging and Obesity-Related Hypogonadism in Men: A Review. Medical Science Monitor, 31. https://doi.org/10.12659/msm.948180
Vancouver
Huang X, Zhao H, Wu X, Liang Y, Guan Q, Luo D, et al. Mechanisms of Leydig Cell Aging and Obesity-Related Hypogonadism in Men: A Review. Medical Science Monitor. 2025;31. doi:10.12659/msm.948180
BibTeX
@article{Huang2025,
author = {Huang, Xinshuang and Zhao, Hui and Wu, Xiaodong and Liang, Yun and Guan, Qingbo and Luo, Dandan and Yu, Chunxiao},
title = {Mechanisms of Leydig Cell Aging and Obesity-Related Hypogonadism in Men: A Review},
journal = {Medical Science Monitor},
year = {2025},
volume = {31},
doi = {10.12659/msm.948180}
}
EUVIMED